Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Reducing Stroke Damage by Cooling the Brain

By HospiMedica staff writers
Posted on 06 Mar 2008
A new collaboration has been formed to examine if cooling the brain could reduce the damage that occurs when the brain is deprived of oxygen immediately following a stroke.

Researchers from Harbin Medical University (HMU, China) and the Hunter Medical Research Institute (HMRI, Newcastle, Australia) are collaborating on advance research into cooling the brain after a stroke. More...
The HMU research team will evaluate the effectiveness of a cooling helmet, while the HMRI Stroke Research Group will investigate intravascular technology that cools the blood. Brain imaging technology pioneered in the HMRI will be used in both the Australia and China trials to assess and compare the effects of the two cooling technologies. The Australian `stroke trial will begin in mid 2008 and the Chinese trial is likely to begin in 2009. The World Health Organization (WHO, Geneva, Switzerland) estimates that stroke affects 15 million people worldwide each year, with five million experiencing lasting disability.

"The collaboration on stroke research with HMU is one example of the University's recent extensive engagement with our counterparts in China,” said Professor Barney Glover, Ph.D., deputy vice-chancellor of research at the HMRI. "This strategic focus on developing our international partnerships is reaping rewards for our students, Hunter researchers and our local community.”

It is not known exactly how hypothermia works to reduce tissue death following a stroke. Scientists researching this technique theorize that hypothermia's protective benefits come from slowing the body's metabolism, which in turn reduces the chemical reactions that lead to brain cell death. Cooling also is known to reduce inflammation, another cause of brain injury after a stroke. Hypothermia may also protect against further damage to brain cells that can occur when clot-busting drugs, such as tissue plasminogen activator (tPA), are used to restore blood flow.


Related Links:
Harbin Medical University
Hunter Medical Research Institute

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Hemostatic Agent
HEMOBLAST Bellows
Emergency Ventilator
Shangrila935
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.